The primary goal of the project is to test personalized medication experiments to inform decisions about future medication use. Our central hypothesis is that our intervention will lead to within subject increases in adolescent involvement in decision making and decreases in uncertainty about future medication use. The investigators view this open label trial as a pilot study to test the feasibility, acceptability, and preliminary efficacy of the medication experiment intervention and therefore warrants further testing in a future larger trial.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Decision Making Involvement Scale [Parent Seek] - Reported by Child
Timeframe: The investigators will reference the Decision-Making Involvement interview guide to collect this measure at (pre) study visit 1 and the stand-alone version (post) 4-12 weeks later at study visit 2.
Decision Making Involvement Scale [Parent Seek] - Parent Report
Timeframe: The investigators will reference the Decision-Making Involvement interview guide to collect this measure at (pre) study visit 1 and the stand-alone version (post) 4-12 weeks later at study visit 2.
Decision Making Involvement Scale [Child Express] - Child Report
Timeframe: The investigators will reference the Decision-Making Involvement interview guide to collect this measure at (pre) study visit 1 and the stand-alone version (post) 4-12 weeks later at study visit 2.
Decision Making Involvement Scale [Child Express] - Parent Report
Timeframe: The investigators will reference the Decision-Making Involvement interview guide to collect this measure at (pre) study visit 1 and the stand-alone version (post) 4-12 weeks later at study visit 2.
Decisional Conflict - Parent Report
Timeframe: The DCS was collected at the first study visit, and then again after the medication experiment was completed (between 4 and 12 weeks later)
Decisional Conflict - Child Report
Timeframe: The DCS was collected at the first study visit, and then again after the medication experiment was completed (between 4 and 12 weeks later)
Decision Making Involvement Scale - Joint/Options
Timeframe: The investigators will reference the Decision-Making Involvement interview guide to collect this measure at study visit 2 (post), which is 4-12 weeks after study visit 1.
Decision Making Involvement Scale - Child Express
Timeframe: The investigators will reference the Decision-Making Involvement Scale and Control Preferences Scale collected at Study Visit 2, which is 4-12 weeks after study visit 1.